Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (119K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Campillos, M.
Right arrow Articles by Vázquez, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campillos, M.
Right arrow Articles by Vázquez, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2003, Vol. 31, No. 5 1571-1575
© 2003 Oxford University Press

Transcriptional activation by AP-2{alpha} is modulated by the oncogene DEK

Mónica Campillos, Miguel Angel García, Fernando Valdivieso and Jesús Vázquez*

Centro de Biología Molecular ‘Severo Ochoa’, CSIC-Universidad Autónoma de Madrid, 28049 Cantoblanco, Madrid, Spain

*To whom correspondence should be addressed. Tel: +34 913 978364; Fax: +34 913 978087; Email: jvazquez{at}cbm.uam.es
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors

Cell differentiation and development are highly regulated processes at the transcriptional level. One of the main transcription factors that regulate these processes is AP-2{alpha}, a cell-type specific protein required for vertebrate development and embryogenesis. AP-2{alpha} also regulates apoptosis and cell-cycle specific events by interacting with the oncogene c-Myc. In searching for novel AP-2{alpha}- interacting factors, using an affinity chromatography approach, we have observed that oncoprotein DEK interacts with AP-2{alpha} in vitro. The existence of an interaction between AP-2{alpha} and DEK in cellular cultures was demonstrated by expression of a tagged AP-2{alpha} form followed by immunodetection. By transient co-expression experiments using a reporter for APOE promoter activity we have found that DEK stimulates the transactivation activity of AP-2{alpha} over APOE promoter. Finally, electrophoretic mobility shift assays suggested that DEK enhances the DNA-binding activity of AP-2{alpha}. Our data suggest a novel cellular function of DEK as a transcriptional co-activator.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
F. Kappes, J. Fahrer, M. S. Khodadoust, A. Tabbert, C. Strasser, N. Mor-Vaknin, M. Moreno-Villanueva, A. Burkle, D. M. Markovitz, and E. Ferrando-May
DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress
Mol. Cell. Biol., May 15, 2008; 28(10): 3245 - 3257.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. M. Wise-Draper, H. V. Allen, E. E. Jones, K. B. Habash, H. Matsuo, and S. I. Wells
Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions
Mol. Cell. Biol., October 15, 2006; 26(20): 7506 - 7519.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Sammons, S. S. Wan, N. L. Vogel, E. J. Mientjes, G. Grosveld, and B. P. Ashburner
Negative Regulation of the RelA/p65 Transactivation Function by the Product of the DEK Proto-oncogene
J. Biol. Chem., September 15, 2006; 281(37): 26802 - 26812.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. C. Mitchell, M. Abdelrahim, J. Weng, L. J. Stafford, S. Safe, M. Bar-Eli, and M. Liu
Regulation of KiSS-1 Metastasis Suppressor Gene Expression in Breast Cancer Cells by Direct Interaction of Transcription Factors Activator Protein-2{alpha} and Specificity Protein-1
J. Biol. Chem., January 6, 2006; 281(1): 51 - 58.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
X. Ding, C. Fan, J. Zhou, Y. Zhong, R. Liu, K. Ren, X. Hu, C. Luo, S. Xiao, Y. Wang, et al.
GAS41 interacts with transcription factor AP-2beta and stimulates AP-2beta-mediated transactivation.
Nucleic Acids Res., January 1, 2006; 34(9): 2570 - 2578.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. M. Wise-Draper, H. V. Allen, M. N. Thobe, E. E. Jones, K. B. Habash, K. Munger, and S. I. Wells
The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7
J. Virol., November 15, 2005; 79(22): 14309 - 14317.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H.-g. Hu, H. Illges, C. Gruss, and R. Knippers
Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes
Int. Immunol., June 1, 2005; 17(6): 789 - 796.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
F. Böhm, F. Kappes, I. Scholten, N. Richter, H. Matsuo, R. Knippers, and T. Waldmann
The SAF-box domain of chromatin protein DEK
Nucleic Acids Res., February 18, 2005; 33(3): 1101 - 1110.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Kappes, I. Scholten, N. Richter, C. Gruss, and T. Waldmann
Functional Domains of the Ubiquitous Chromatin Protein DEK
Mol. Cell. Biol., July 1, 2004; 24(13): 6000 - 6010.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Kappes, C. Damoc, R. Knippers, M. Przybylski, L. A. Pinna, and C. Gruss
Phosphorylation by Protein Kinase CK2 Changes the DNA Binding Properties of the Human Chromatin Protein DEK
Mol. Cell. Biol., July 1, 2004; 24(13): 6011 - 6020.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. Waldmann, M. Baack, N. Richter, and C. Gruss
Structure-specific binding of the proto-oncogene protein DEK to DNA
Nucleic Acids Res., December 1, 2003; 31(23): 7003 - 7010.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.